Chemoinformaics analysis of 9,10-Anthracenedione, 1-hydroxy-3-methyl-
| Molecular Weight | 238.242 | nRot | 0 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 18 |
| Exact Molecular Weight | 238.063 | nRing | 3 |
| Solubility: LogS | -5.072 | nHRing | 0 |
| Solubility: LogP | 2.706 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 34.1239 |
| nHD | 1 | BPOL | 11.7681 |
| QED | 0.528 |
| Synth | 3.866 |
| Natural Product Likeliness | 1.309 |
| NR-PPAR-gamma | 0.035 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.091 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.789 |
| MDCK | 0.0000255 |
| BBB | 0.101 |
| PPB | 0.97785 |
| VDSS | 0.751 |
| FU | 0.0090066 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.833 |
| CYP2c19-inh | 0.266 |
| CYP2c19-sub | 0.718 |
| CYP2c9-inh | 0.534 |
| CYP2c9-sub | 0.292 |
| CYP2d6-inh | 0.324 |
| CYP2d6-sub | 0.344 |
| CYP3a4-inh | 0.636 |
| CYP3a4-sub | 0.279 |
| CL | 1.583 |
| T12 | 0.071 |
| hERG | 0.016 |
| Ames | 0.815 |
| ROA | 0.276 |
| SkinSen | 0.173 |
| Carcinogencity | 0.625 |
| EI | 0.126 |
| Respiratory | 0.355 |
| NR-Aromatase | 0.423 |
| Antiviral | Yes |
| Prediction | 0.676142 |